A Phase 1 study of YJ001 spray for diabetic neuropathic pain
Recruiting Phase 1 NCT06361108
Study Description
A study to evaluate the safety, tolerability, and effectiveness of a new topical spray medication (YJ001) for diabetic neuropathic pain
Study Details
- Registry ID:
- NCT06361108
- Conditions:
- Diabetic Peripheral Neuropathic Pain
- Phase:
- Phase 1
- Target Enrollment:
- 24 participants
- Start Date:
- Age Range:
- 18–80 years
- Healthy Volunteers:
- No
Study Locations (1 site)
-
Clinical Trials of Texas,LLC
Fredericksburg, Texas, United States
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.